HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs

NCT06155123 · clinicaltrials.gov ↗

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Migraine Disorders
Chronic Migraine
Episodic Migraine

Interventions

DRUG: Monoclonal antibody targeting the CGRP pathway (ligand or receptor) (mAbs)

Sponsor

IRCCS National Neurological Institute "C. Mondino" Foundation